Adenosine A_2A agonists in development for the treatment of inflammation

Author： Lappas Courtney M Sullivan Gail W Linden Joel

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.7, 2005-07, pp. : 797-806

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medicinal Chemistry of Adenosine A2A Receptor Agonists

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 4, 2003-02 ,pp. : 387-401

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR analysis of 2-alkyloxy and 2-aralkyloxy adenosine A 1 - and A 2 -agonists

By Matova M. Nacheva R. Boicheva S.

European Journal of Medicinal Chemistry, Vol. 32, Iss. 6, 1997-06 ,pp. : 505-513

Elsevier

Access to resources Recommend Favorite

The Adenosine A2b Receptor: Its Role in Inflammation

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 4, 2008-12 ,pp. : 244-254

Bentham Science Publishers

Access to resources Recommend Favorite

Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning

By van Helden H.P.M. Bueters T.J.H.

Trends in Pharmacological Sciences, Vol. 20, Iss. 11, 1999-11 ,pp. : 438-441

Elsevier

Access to resources Recommend Favorite

Adenosine receptor agonists: from basic medicinal chemistry to clinical development

By Yan Luo Burbiel Joachim C Maaß Astrid Müller Christa E

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 537-576

Informa Healthcare

Access to resources Recommend Favorite